These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27371909)

  • 21. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.
    Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W
    Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal-averaged and standard electrocardiography in patients with newly diagnosed epilepsy.
    Svalheim S; Aurlien D; Amlie JP; Gjerstad L; Taubøll E
    Epilepsy Behav; 2012 Dec; 25(4):543-5. PubMed ID: 23153719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paradoxical effect of ajmaline in a patient with Brugada syndrome.
    Sassone B; Saccà S; Donateo M
    Europace; 2006 Apr; 8(4):251-4. PubMed ID: 16627450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of early repolarization (J wave) and ST-segment morphology after J wave in Brugada syndrome: multicenter study in Japan.
    Takagi M; Aonuma K; Sekiguchi Y; Yokoyama Y; Aihara N; Hiraoka M;
    Heart Rhythm; 2013 Apr; 10(4):533-9. PubMed ID: 23274366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brugada-Phenocopy Induced by Propafenone Overdose and Successful Treatment: A Case Report.
    Arı ME; Ekici F
    Balkan Med J; 2017 Sep; 34(5):473-475. PubMed ID: 28381391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of early repolarization pattern in inferolateral leads in patients with Brugada syndrome.
    Letsas KP; Sacher F; Probst V; Weber R; Knecht S; Kalusche D; Haïssaguerre M; Arentz T
    Heart Rhythm; 2008 Dec; 5(12):1685-9. PubMed ID: 19084806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brugada-like electrocardiographic pattern induced by lamotrigine toxicity.
    Strimel WJ; Woodruff A; Cheung P; Kirmani BF; Stephen Huang SK
    Clin Neuropharmacol; 2010; 33(5):265-7. PubMed ID: 20864838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brugada-like electrocardiographic patterns induced by hyperkalemia.
    Reingardienė D; Vilčinskaitė J; Bilskienė D
    Medicina (Kaunas); 2013; 49(3):148-53. PubMed ID: 23893060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of ventricular late potentials in signal-averaged ECG of people with epilepsy.
    Rejdak K; Rubaj A; Głowniak A; Furmanek K; Kutarski A; Wysokiński A; Stelmasiak Z
    Epilepsia; 2011 Nov; 52(11):2118-24. PubMed ID: 21933183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into the location of type I ECG in patients with Brugada syndrome: correlation of ECG and cardiovascular magnetic resonance imaging.
    Veltmann C; Papavassiliu T; Konrad T; Doesch C; Kuschyk J; Streitner F; Haghi D; Michaely HJ; Schoenberg SO; Borggrefe M; Wolpert C; Schimpf R
    Heart Rhythm; 2012 Mar; 9(3):414-21. PubMed ID: 22119454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy.
    Canevini MP; De Sarro G; Galimberti CA; Gatti G; Licchetta L; Malerba A; Muscas G; La Neve A; Striano P; Perucca E;
    Epilepsia; 2010 May; 51(5):797-804. PubMed ID: 20545754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lacosamide induced Brugada I morphology in the setting of septicemia: A case report.
    Goodnough R; Badea A; Geier C; Lynch KL; LeSaint KT
    Medicine (Baltimore); 2021 May; 100(18):e25577. PubMed ID: 33950934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability of the diagnostic ECG pattern in an ICD patient population with Brugada syndrome.
    Richter S; Sarkozy A; Veltmann C; Chierchia GB; Boussy T; Wolpert C; Schimpf R; Brugada J; Brugada R; Borggrefe M; Brugada P
    J Cardiovasc Electrophysiol; 2009 Jan; 20(1):69-75. PubMed ID: 18775043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification.
    Veltmann C; Schimpf R; Echternach C; Eckardt L; Kuschyk J; Streitner F; Spehl S; Borggrefe M; Wolpert C
    Eur Heart J; 2006 Nov; 27(21):2544-52. PubMed ID: 16952922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should all individuals with a nondiagnostic Brugada-electrocardiogram undergo sodium-channel blocker test?
    Zorzi A; Migliore F; Marras E; Marinelli A; Baritussio A; Allocca G; Leoni L; Perazzolo Marra M; Basso C; Buja G; Thiene G; Iliceto S; Delise P; Corrado D
    Heart Rhythm; 2012 Jun; 9(6):909-16. PubMed ID: 22334153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationships between depolarization abnormality and repolarization abnormality in patients with Brugada syndrome: using body surface signal-averaged electrocardiography and body surface maps.
    Hisamatsu K; Kusano KF; Morita H; Takenaka S; Nagase S; Nakamura K; Emori T; Matsubara H; Mikouchi H; Nishizaki Y; Ohe T
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):870-6. PubMed ID: 15333077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventricular late potential in patients with apparently normal electrocardiogram; predictor of Brugada syndrome.
    Mizobuchi M; Enjoji Y; Nakamura S; Muranishi H; Utsunomiya M; Funatsu A; Kobayashi T
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):266-73. PubMed ID: 19954504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive use of ezogabine/retigabine with either traditional sodium channel blocking antiepileptic drugs (AEDs) or AEDs with other mechanisms of action: Evaluation of efficacy and tolerability.
    Brodie MJ; French JA; McDonald SA; Lee WJ; Adams B; Scott A; Nohria V; DeRossett S
    Epilepsy Res; 2014 Jul; 108(5):989-94. PubMed ID: 24726452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and electrocardiographic predictors of positive response to the intravenous sodium channel blockers in patients suspected of the Brugada syndrome.
    Shahrzad S; Khoramshahi M; Aslani A; Fazelifar AF; Haghjoo M
    Int J Cardiol; 2013 May; 165(2):285-90. PubMed ID: 21917337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.